H-Abu-NH2
|
|
7324-11-0
|
1-Methyl-L-histidine
|
1-甲基-L-組氨酸
|
332-80-9
|
2,4,6-Trifluorophenylboronic acid
|
2,4,6-三氟苯硼酸
|
182482-25-3
|
5-chloropyrimidine
|
|
17180-94-8
|
Z-D-Leu-ONp
|
|
52235-17-3
|
3-methoxymethyl-pyridine
|
|
58418-62-5
|
L-trans-Epoxysuccinyl-Ile-Pro-OH propylamide
|
|
134448-10-5
|
H-His-Pro-Phe-His-Leu-D-Leu-Val-Tyr-OH
|
|
50410-01-0
|
H-Leu-Phe-Ala-OH.AcOH
|
|
|
Di-tert-butyl(methyl)phosphonium tetrafluoroborate
|
四氟硼酸二叔丁基甲基膦?鹽
|
870777-30-3
|
H-Phe-Ile-OH
|
|
22951-94-6
|
C-Reactive Protein (CRP) (77-82)
|
|
130349-01-8
|
rec IL-10 (murine)
|
|
|
H-Trp-Phe-Tyr-Ser(PO3H2)-Pro-Arg-AMC
|
|
|
(Tyr36)-pTH-Related Protein (1-36) (human, mouse, rat)
|
|
|
3-(N-Boc-amino)phenylboronic acid pinacol ester
|
3-(Boc-氨基)苯硼酸頻哪酯
|
330793-09-4
|
Fmoc-Asp(OMpe)-OH
|
|
180675-08-5
|
Fmoc-D-Lys(Boc)-OPfp
|
|
133083-36-0
|
4-Sulfonamide-phenylhydrazine hydrochloride
|
4-磺酰胺基苯肼鹽酸鹽
|
27918-19-0
|
H-Orn(Z)-OBzl HCl
|
|
63594-37-6
|
2-(N,N-dimethylamino)pyridine
|
|
5683-33-0
|
Z-Orn(Fmoc)-OH
|
|
201048-68-2
|
H-Asn(GlcNAc-β-D)-OH
|
|
2776-93-4
|
BOC-D-PRO-OSU
|
BOC-D-脯氨酸羥基琥珀酰亞胺硬脂酸酯
|
102185-34-2
|
Z-D-Lys(Boc)-OSu
|
|
78603-23-3
|
2-Chloropyridine-3-boronic acid
|
2-氯吡啶-3-硼酸
|
381248-04-0
|
2-Mesitylmagnesium bromide solution 1.0M in diethyl ether
|
2,4,6-三甲基苯基溴化鎂
|
2633-66-1
|
2-Fluoro-6-isopropoxyphenylboronic acid
|
2-氟-6-異丙氧基苯硼酸
|
870777-17-6
|
2-Amino-4-bromopyridine
|
2-氨基-4-溴吡啶
|
84249-14-9
|
Boc-Orn(2-chloro-Z)-OH
|
|
118554-00-0
|
Fmoc-Lys(4-methoxytrityl)-OH
|
|
159857-60-0
|
N-Boc-D-3-Amino-3-(4-methylphenyl)propanoic acid
|
N-Boc-D-3-氨基-3-(4-甲基苯基)丙酸
|
479064-97-6
|
3-Formylphenylboronic acid
|
3-甲酰基苯硼酸
|
87199-16-4
|
N-(5-bromopyridin-2-yl)-5-chloro-1H-indole-2-carboxamide
|
|
620596-72-7
|
2,4-Bis-tert-butylsulfanyl-6-methyl-pyrimidine
|
|
85591-52-2
|
3-(Ethoxycarbonyl)phenylzinc iodide solution 0.5M in THF
|
3-(乙氧羰基)苯基鋅碘化物
|
282727-18-8
|
N4,N4-diethyl-6-methyl-pyrimidine-2,4-diamine
|
|
90770-67-5
|
6-Ethoxy-6-oxohexylzinc bromide solution 0.5M in THF
|
6-乙氧基-6-氧己基溴化鋅
|
312693-01-9
|
5-Bromo-2-fluorophenylboronic acid MIDA ester
|
5-溴-2-氟苯硼酸甲基亞氨基二乙酸酯
|
|
2-(Dicyclohexylphosphino)-1-phenylindole 95% (NMR)
|
|
740815-36-5
|
2,6-Difluoro-3-methoxyphenylboronic acid
|
2,6-二氟-3-甲氧基苯硼酸
|
870779-02-5
|
Fmoc-Cys(3-(Boc-amino)-propyl)-OH
|
|
173963-91-2
|
H-Arg-Tyr-NH2
|
|
|
Fmoc-(S)-3-Amino-4-(2-thienyl)-butyric acid
|
|
269726-90-1
|
Motilin (canine)
|
|
85490-53-5
|
Pyr-Trp-Lys-Leu-Gly-Arg-Phe-Gly-Tyr-OH
|
|
|
Chloranilic acid barium salt trihydrate
|
氯冉酸鋇三水
|
32458-20-1
|
Z-D-Val-Leu-OH
|
|
74202-02-1
|
Z-Tyr-Val-Ala-Asp-chloromethylketone
|
|
|
Thymic Factor
|
|
63958-90-7
|
Z-Ile-Gly-OH
|
|
13254-04-1
|
Fmoc-(R)-3-Amino-4-(4-pyridyl)-butyric acid
|
|
269396-69-2
|
Boc-(R)-3-Amino-3-(4-nitro-phenyl)-propionic acid
|
|
|
5-Benzyloxy-6-methoxyindole
|
5-芐氧基-6-甲氧基吲哚
|
4790-04-9
|
Neuropeptide γ
|
|
114882-65-4
|
Cesium orthovanadate
|
原釩酸銫
|
34283-69-7
|
H-His-Leu-Leu-Val-Phe-OMe
|
|
|
rec IFN-γ (human)
|
|
|
(D-Phe12,Nle21·38)-CRF (12-41) (human, rat)
|
|
129133-27-3
|
Characteristic MSH-Tetrapeptide
|
|
|
IGF-I Analog
|
|
147819-32-7
|
H-Ser-Ile-Lys-Val-Ala-Val-OH
|
|
|
Toxic Shock Syndrome Toxin-1 (TSST-1) (58-78)
|
|
137593-46-5
|
2-bromo-3-pyridinecarboxylic acid
|
|
35905-85-2
|
2-iodo-6-methyl-pyridine
|
|
62674-71-9
|
2-(3,4-Dimethyl-phenoxy)-5-nitro-pyridine
|
|
76893-52-2
|
(Deamino-Cys1,Lys8)-Vasopressin
|
|
2989-84-6
|
L-7-Hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
|
L-7-羥基-1,2,3,4-四氫異喹啉-3-羧酸
|
128502-56-7
|
Boc-Asp-OFm
|
|
129046-87-3
|
Boc-Cys(NPys)-OH
|
|
76880-29-0
|
Ac-Ile-NH2
|
|
56711-06-9
|
H-Arg-Trp-OH
|
|
25615-38-7
|
Z-Tyr(tBu)-OMe
|
|
5068-29-1
|
(R)-3-Amino-3-phenylpropionic acid
|
|
83649-48-3
|
Fmoc-D-3-Amino-4-(2-chlorophenyl)butyric acid
|
Fmoc-D-3-氨基-4-(2-氯苯基)丁酸
|
268734-29-8
|
4-[(1-Naphthyloxy)methyl]phenylboronic acid
|
4-[(1-萘氧基)甲基]苯硼酸
|
871125-78-9
|
1-Boc-4-bromopyrazole
|
|
1150271-23-0
|
6-hydrazinopyridine-3-carboxylic acid
|
|
133081-24-0
|
Tris(2,6-dimethoxyphenyl)phosphine
|
三(2,6-二甲氧基苯基)磷
|
85417-41-0
|
1-(4-methoxybenzoyl)indole-3-carbaldehyde
|
|
602330-19-8
|
Tantalum(V) butoxide
|
丁醇鉭
|
51094-78-1
|
rec IGF-II (1-67) (human)
|
|
96081-16-2
|
Suc-Ala-Ala-Pro-Phe-AMC
|
|
88467-45-2
|
(p-Chloro-D-Phe6,Leu17)-VIP (human, bovine, porcine, rat)
|
|
102805-45-8
|
Ac-Arg-Leu-Arg-AMC
|
|
929903-87-7
|
3-(4-chlorophenylthio)-5-methoxy-1H-indole
|
|
955125-50-5
|
Acenaphthene-5-boronic acid
|
苊-5-硼酸
|
183158-33-0
|
5-bromo-2-iodopyridine
|
|
223463-13-6
|
3,4-Dibenzyloxybenzaldehyde
|
3,4-二芐氧基苯甲醛
|
5447-02-9
|
Z-Pro-Phe-OH
|
|
17350-17-3
|
H-Pro-Gly-Arg-Tyr-NH2
|
|
739356-98-0
|
H-D-Ala-Gly-OH
|
|
3997-90-8
|
trans-1-Octen-1-ylboronic acid pinacol ester
|
1-辛基硼酸頻哪醇酯
|
83947-55-1
|
Spaglumic acid
|
|
3106-85-2
|
Pentafluorophenylmagnesium bromide solution 0.5M in diethyl ether
|
五氟苯基溴化鎂
|
879-05-0
|
H-Tyr-Trp-NH2
|
|
|
H-Met-Pro-OH
|
|
142702-34-9
|
Boc-R-3-Amino-4-(3,4-dichloro-phenyl)butyric acid
|
Boc-R-3-氨基-4-(3,4-二氯苯基)丁酸
|
269396-56-7
|
Z-Gly-Tyr-OH
|
|
7801-35-6
|
HIV Protease Substrate VIII
|
|
|